{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:43:16Z","timestamp":1792478596709,"version":"4.5.0"},"reference-count":38,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15847","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:30:29Z","timestamp":1788521429000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological characteristics and potential impact of previous treatment history in metachronous contralateral breast cancer: Insights from a real\u2011world retrospective study"],"prefix":"10.3892","volume":"32","author":[{"given":"Ritsuko","family":"Sasaki","sequence":"first","affiliation":[{"name":"Department of Breast Oncology, Juntendo University Graduate School of Medicine, Tokyo 113\u20118421, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Kanagawa 236\u20110027, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Iijima","sequence":"additional","affiliation":[{"name":"Department of Breast Oncology, Juntendo University Graduate School of Medicine, Tokyo 113\u20118421, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Breast Oncology, Juntendo University Graduate School of Medicine, Tokyo 113\u20118421, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsue","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Breast Oncology, Juntendo University Graduate School of Medicine, Tokyo 113\u20118421, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goro","family":"Kutomi","sequence":"additional","affiliation":[{"name":"Department of Breast Oncology, Juntendo University Graduate School of Medicine, Tokyo 113\u20118421, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"key20261020093148_b1-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3892\/ol.2024.14523","article-title":"Survival analysis for patients with metachronous contralateral breast cancer: Insights from a retrospective study","volume":"28","author":"Park","year":"2024","journal-title":"Oncol Lett"},{"key":"key20261020093148_b2-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4048\/jbc.2019.22.e18","article-title":"Comparative analysis of outcomes and clinicopathological characteristics of synchronous and metachronous contralateral breast cancer: A study of the SEER database","volume":"22","author":"Qiu","year":"2019","journal-title":"J Breast Cancer"},{"key":"key20261020093148_b3-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"13649","DOI":"10.1002\/cam4.5979","article-title":"The changes of subtype markers between first and second primary breast cancers","volume":"12","author":"Li","year":"2023","journal-title":"Cancer Med"},{"key":"key20261020093148_b4-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1200\/JCO.2010.32.7395","article-title":"Declining incidence of contralateral breast cancer in the United States from 1975 to 2006","volume":"29","author":"Nichols","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20261020093148_b5-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10549-010-1057-y","article-title":"Bilateral breast cancer: Analysis of incidence, outcome, survival and disease characteristics","volume":"126","author":"Kheirelseid","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"key20261020093148_b6-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10549-019-05363-0","article-title":"National trends of synchronous bilateral breast cancer incidence in the United States","volume":"178","author":"Sakai","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"key20261020093148_b7-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/jnci\/djz010","article-title":"The influence of adjuvant systemic regimens on contralateral breast cancer risk and receptor subtype","volume":"111","author":"Kramer","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"key20261020093148_b8-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/SLA.0000000000001698","article-title":"Growing use of contralateral prophylactic mastectomy despite no improvement in long-term survival for invasive breast cancer","volume":"265","author":"Wong","year":"2017","journal-title":"Ann Surg"},{"key":"key20261020093148_b9-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/jcm7060133","article-title":"Patterns of occurrence and outcomes of contralateral breast cancer: Analysis of SEER data","volume":"7","author":"Xiong","year":"2018","journal-title":"J Clin Med"},{"key":"key20261020093148_b10-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur J Cancer"},{"key":"key20261020093148_b11-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10549-018-4846-3","article-title":"Mortality after contralateral breast cancer in Denmark","volume":"171","author":"Langballe","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"key20261020093148_b12-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2019.07.008","article-title":"Synchronous and metachronous bilateral breast cancer: Clinicopathologic characteristics and prognostic outcomes","volume":"92","author":"Mruthyunjayappa","year":"2019","journal-title":"Hum Pathol"},{"key":"key20261020093148_b13-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1002\/cam4.2198","article-title":"The prognostic comparison among unilateral, bilateral, synchronous bilateral, and metachronous bilateral breast cancer: A meta-analysis of studies from recent decade (2008\u20132018)","volume":"8","author":"Pan","year":"2019","journal-title":"Cancer Med"},{"key":"key20261020093148_b14-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10549-015-3538-5","article-title":"Bilateral breast cancer, synchronous and metachronous; differences and outcome","volume":"153","author":"Jobsen","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"key20261020093148_b15-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00432-011-1141-7","article-title":"Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer","volume":"138","author":"Shi","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20261020093148_b16-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1200\/JCO.2011.39.3645","article-title":"Tumor stage affects risk and prognosis of contralateral breast cancer: Results from a large Swedish-population-based study","volume":"30","author":"Vichapat","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20261020093148_b17-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s12885-021-08132-9","article-title":"Increased risk of breast cancer-specific mortality among cancer survivors who developed breast cancer as a second malignancy","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Cancer"},{"key":"key20261020093148_b18-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1470-2045(05)70174-1","article-title":"Genetic implications of bilateral breast cancer: A population based cohort study","volume":"6","author":"Hartman","year":"2005","journal-title":"Lancet Oncol"},{"key":"key20261020093148_b19-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/jnci\/djp181","article-title":"Second primary breast cancer occurrence according to hormone receptor status","volume":"101","author":"Kurian","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"key20261020093148_b20-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10549-020-05611-8","article-title":"Prediction of contralateral breast cancer: External validation of risk calculators in 20 international cohorts","volume":"181","author":"Giardiello","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"key20261020093148_b21-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.breast.2018.11.005","article-title":"Risk factors for metachronous contralateral breast cancer: A systematic review and meta-analysis","volume":"44","author":"Akdeniz","year":"2019","journal-title":"Breast"},{"key":"key20261020093148_b22-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1200\/JCO.2017.77.3424","article-title":"Breast cancer family history and contralateral breast cancer risk in young women: An update from the women's environmental cancer and radiation epidemiology study","volume":"36","author":"Reiner","year":"2018","journal-title":"J Clin Oncol"},{"key":"key20261020093148_b23-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1054\/bjoc.2000.1603","article-title":"Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in Southeast England","volume":"84","author":"Evans","year":"2001","journal-title":"Br J Cancer"},{"key":"key20261020093148_b24-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","article-title":"Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program","volume":"12","author":"Hayat","year":"2007","journal-title":"Oncologist"},{"key":"key20261020093148_b25-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1158\/1055-9965.EPI-25-1298","article-title":"Identifying locally recurrent versus second primary breast cancer: Genomic versus clinical criteria from carolina breast cancer study phase III","volume":"35","author":"Van Alsten","year":"2026","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20261020093148_b26-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"key20261020093148_b27-ol-32-5-15847","first-page":"107","article-title":"Adjuvant endocrine therapy and risk of contralateral breast cancer: A systematic review and meta-analysis of observational studies","volume":"36","author":"Ghosh","year":"2025","journal-title":"Cancer Causes Control"},{"key":"key20261020093148_b28-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.surg.2015.03.059","article-title":"Clinicopathologic features and time interval analysis of contralateral breast cancers","volume":"158","author":"Liederbach","year":"2015","journal-title":"Surgery"},{"key":"key20261020093148_b29-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/jamaoncol.2026.1465","article-title":"Circulating tumor DNA in early breast cancer: A review","volume":"12","author":"Schlam","year":"2026","journal-title":"JAMA Oncol"},{"key":"key20261020093148_b30-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13058-017-0874-x","article-title":"Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population","volume":"19","author":"Reiner","year":"2017","journal-title":"Breast Cancer Res"},{"key":"key20261020093148_b31-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13058-016-0726-0","article-title":"Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE study","volume":"18","author":"Langballe","year":"2016","journal-title":"Breast Cancer Res"},{"key":"key20261020093148_b32-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"6865","DOI":"10.1158\/0008-5472.CAN-09-1355","article-title":"Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res"},{"key":"key20261020093148_b33-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10549-007-9709-2","article-title":"The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: A population based study in the Netherlands","volume":"110","author":"Schaapveld","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"key20261020093148_b34-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","article-title":"Overcoming endocrine resistance in breast cancer","volume":"37","author":"Hanker","year":"2020","journal-title":"Cancer Cell"},{"key":"key20261020093148_b35-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years","volume":"377","author":"Pan","year":"2017","journal-title":"N Eng J Med"},{"key":"key20261020093148_b36-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1001\/jamaoncol.2016.3340","article-title":"Association of adjuvant tamoxifen and aromatase inhibitor therapy with contralateral breast cancer risk among US women with breast cancer in a general community setting","volume":"3","author":"Gierach","year":"2017","journal-title":"JAMA Oncology"},{"key":"key20261020093148_b37-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1470-2045(17)30891-4","article-title":"Germline BRCA mutation and outcome in young-onset breast cancer (POSH): A prospective cohort study","volume":"19","author":"Copson","year":"2018","journal-title":"Lancet Oncol"},{"key":"key20261020093148_b38-ol-32-5-15847","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1186\/s12885-019-6139-6","article-title":"Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Cancer"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:31:53Z","timestamp":1792477913000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,4]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15847","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]}}}